Electrospun nanofibers mimic the bone’s extra-cellular matrix and represent an alternative implant coating to enhance implant osseointegration. Approximately 99% of the strontium (Sr2+) in our body deposits in the bone and serves as a stimulator of bone formation. The purpose of this study was to develop an Sr2+-doped coaxial polycaprolactone (PCL)/poly(D,L-lactide-co-glycolide) (PLGA)-polyvinyl alcohol (PVA) nanofiber coating to enhance the osseointegration. An optimized PCL/PLGA (1:1 v/v) sheath fiber formula was identified to match the nanofibers degradation to the implant osseointegration physiology. Scanning electron microscopy images showed that the Sr2+-doped nanofibers had a less dense structure and larger porosity than the nanofibers without Sr2+ doping. A sustained Sr2+ release from the PCL/PLGA-PVA coaxial nanofibers was observed for over two months. The indirect and direct cellular contact studies confirmed the biocompatibility of the Sr2+-doped PCL/PLGA-PVA coaxial nanofibers. The Sr2+-doped nanofibers provided further and significant enhancement of the differentiation of murine pre-osteoblast MC3T3-E1 cells. These findings indicate that Sr2+-doped PCL/PLGA-PVA coaxial nanofibers have a great potential to be applied as a new implant coating matrices.
27 May 2022 in Journal of Biomaterials Applications
Prosthesis with antibiotic-eluting nanofibrous (NF) coating represents coating alternative to prevent periprosthetic joint infection (PJI). In this study, four formulas of erythromycin (EM)-embedded both in core and sheath components of coaxial PCL/PLGA-PVA NF coatings were developed: EM 0 (no EM), EM 100 (100 μg/mL), EM500 (500 μg/mL) and EM1000 (1000 μg/mL). EM doping altered the physicochemical and structural properties of NFs to some extent, including the increase of NF porosity and surface wettability. A sustained EM release from EM-NFs for >4 weeks was observed. Eluents collected from EM-NFs showed strong zone of inhibition (ZOI) to Staphylococcus aureus growth and the sizes of ZOI positively related to the amount of EM released. EM-NFs were nontoxic to rat bone marrow stem cells (rBMSCs). Cell growth was significantly enhanced when comparing rBMSCs cultured on EM-NFs (EM0 and EM 100) to those cultured on NF-free control. Cell differentiation (ALP activity) was notably enhanced by EM100, compared to control and EM0. Eluents from EM-NFs on rBMSCs were also investigated. The presence of 10% EM-NF eluents inhibited the growth of rBMSCs, which was proportional to the amount of EM doped. The ALP activity was notably enhanced by eluents from EM-NFs with the highest activity in EM100 compared to control and EM0. Our data indicate that EM-doped PCL/PLGA-PVA coaxial NF coatings have a great potential to be applied as a new implant coating matrices. Further in vivo testing in animal models is currently planned that should represent the first step in predicting the clinical outcomes of EM-eluting NF coating approach.